| Type | % of AMI | Mechanism | Key Clue |
|---|---|---|---|
| Arterial embolism (SMA) (~50%) | Most common | Embolus from heart (Afib, LV thrombus, valvular) lodges in SMA | Sudden onset severe pain. Afib is the #1 risk factor. Pain out of proportion to exam. |
| Arterial thrombosis (~25%) | Thrombosis at atherosclerotic plaque (usually SMA origin) | History of chronic mesenteric ischemia (postprandial pain, food fear, weight loss) → acute event. | |
| Mesenteric venous thrombosis (~10%) | SMV thrombosis → venous congestion → mucosal ischemia | More insidious onset (days). Risk: hypercoagulable states, portal HTN, recent surgery, OCP use. | |
| Non-occlusive (NOMI) (~15%) | Splanchnic vasoconstriction in low-flow states | ICU patients on vasopressors, post-cardiac surgery, hemodialysis, shock. No clot -vasospasm. |
| Test | Findings |
|---|---|
| CT angiography (CTA) TEST OF CHOICE | Sensitivity > 95%. [ACG Guidelines, Defined 2005 Shows arterial/venous filling defects, bowel wall thickening, pneumatosis (gas in bowel wall = necrosis), portal venous gas, free fluid. |
| Lactate | Elevated (often > 4). But normal lactate does not exclude early AMI. Trend is more useful than single value. |
| Plain X-ray | Late findings: pneumatosis intestinalis, portal venous gas, free air (perforation). Normal X-ray does not rule out AMI. |
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Heparin | 80U/kg→18U/kg/hr | IV | All types |
| Pip-tazo | 4.5g q6h | IV | If peritonitis |
| IVF aggressive | NS/LR | IV | Third-spacing |
| Papaverine | 30-60mg/hr IA | IA | NOMI only |
Patient: 72F with Afib (not on anticoagulation). Sudden severe periumbilical pain × 4h, nausea, bloody diarrhea. HR 110, BP 95/60. Abdomen: diffuse tenderness but soft, no rebound. Lactate 5.2, WBC 19K.
Key findings: Pain out of proportion to exam, classic for early mesenteric ischemia. Afib without anticoagulation = #1 risk for SMA embolism. Elevated lactate confirms tissue ischemia.
Management:
Teaching point: The golden window for mesenteric ischemia is before peritoneal signs develop. Once the abdomen becomes rigid, bowel necrosis is likely irreversible. A soft abdomen with severe pain = act now.
Patient: 68M in ICU on norepinephrine 0.3 mcg/kg/min for cardiogenic shock post-MI. Develops abdominal distension, bloody NG output, rising lactate 3.2 → 7.8. WBC 24K.
Key findings: Non-occlusive mesenteric ischemia, splanchnic vasoconstriction from shock + vasopressors. No embolic source. CTA may show patent but narrowed mesenteric vessels with poor bowel wall enhancement.
Management:
Teaching point: NOMI accounts for ~20% of mesenteric ischemia and has the highest mortality (60-80%) because the underlying cause (shock) is often difficult to reverse. The treatment is hemodynamic optimization, not anticoagulation or surgery.
Patient: 65F smoker with PVD. Postprandial epigastric pain × 6 months, occurring 15-30 min after eating, lasting 1-2h. "Food fear", eating less, lost 20 lb. CTA: > 70% stenosis of SMA and celiac artery.
Key findings: Classic chronic mesenteric ischemia triad: postprandial pain + food avoidance + weight loss. Requires ≥ 2 of 3 mesenteric vessels to be stenotic for symptoms (collateral supply compensates for single vessel disease).
Management:
Teaching point: Chronic mesenteric ischemia is the "angina of the gut." The diagnosis is often delayed because postprandial pain has a broad differential. Weight loss + food fear + vascular risk factors should trigger CTA of mesenteric vessels.